ナミキ商事株式会社 医薬品及び創薬化学品の専門商社

医薬品及び創薬化学品の専門商社

検索検索

バイオ製品Bio Products

タンパク質(癌免疫療法用)

ACROBiosystems社 プロダクトリスト:Recombinant Protein

サプライヤー
AcroBioSystems
カタログNo.
IL7-H4219
製品名称
ActiveMax Recombinant Human IL-7
タンパク質名
IL-7
Species
Human
HOST
HEK293
20ug: 42,000円
お問い合わせ
50ug: 95,000円
お問い合わせ

Overview

Synonyms IL7,Interleukin-7
Characteristics This protein carries no "tag". The protein has a calculated MW of 17 kDa. The protein migrates as 24 kDa and 26 kDa under reducing (R) condition (SDS-PAGE) due to different glycosylation.
Endotoxin Level Less than 1.0 EU per μg by the LAL method.
Purity >95% as determined by SDS-PAGE.
Description Interleukin 7 is also known as IL7, IL-7, and is a hematopoietic growth factor secreted by stromal cells in the red marrow and thymus. It is also produced by keratinocytes, dendritic cells, hepatocytes, neurons, and epithelial cells, but is not produced by lymphocytes. IL-7 stimulates the differentiation of multipotent (pluripotent) hematopoietic stem cells into lymphoid progenitor cells, It also stimulates proliferation of all cells in the lymphoid lineage (B cells, T cells and NK cells). It is important for proliferation during certain stages of B-cell maturation, T and NK cell survival, development and homeostasis. IL-7 is a cytokine important for B and T cell development. This cytokine and the hepatocyte growth factor (HGF) form a heterodimer that functions as a pre-pro-B cell growth-stimulating factor. IL-7 binds to the IL-7 receptor, a heterodimer consisting of Interleukin-7 receptor alpha and common gamma chain receptor. Il-7 promotes hematological malignacies (acute lymphoblastic leukemia, T cell lymphoma). Elevated levels of IL-7 have also been detected in the plasma of HIV-infected patients. IL-7 as an immunotherapy agent has been examined in many pre-clinical animal studies and more recently in human clinical trials for various malignancies and during HIV infection. IL-7 could also be beneficial in improving immune recovery after allogenic stem cell transplant.
Reference (1) Heufler C, et al. 1993, J. Exp. Med. 178 (3): 1109?14.
(2) Kr?ncke R, et al. 1996, Eur. J. Immunol. 26 (10): 2541?4.
(3) Sawa Y, et al. 2009, Immunity 30 (3): 447?57.
(4) Muegge K, et al. 1993, Science 261 (5117): 93?5.
(5) Noguchi M, et al. 1994, Science 262 (5141): 1877?80.
(6) Snyder KM,et al. 2006, Leuk. Lymphoma 47 (7): 1222?8.
URL https://www.acrobiosystems.com/P317-Human-IL-7-Interleukin-7-Protein-HEK293-expressedActiveMax.html

お問い合わせリスト(-)

お問い合わせフォーム